Precision Cancer Therapy in Rare Cancers

Clinical trial NCT06119789 · RECRUITING

Trial details

NCT number: NCT06119789
Sponsor: Oslo University Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Rare Malignant Neoplasm

Start date: 2025-03-20
Primary completion: 2033-11-30
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.